Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?

To: Perry who wrote (1884)	4/6/1998 8:44:00 AM
From: sds	Read Replies (2) \| Respond to of 4676

AA, MZ, emil, other veterans.... Do you still think this is the "next Microsoft"? I was doing some thinking over the weekend and began to wonder about the original investment thesis here. They've now had three drug "failures" -- the wart drug, the AIDS drug, and, apparently, the indication for psoriasis. Yes, I know, they are now working on a topical application, but that still doesn't bode too well... So, what are we left with? Formavirsen -- which treats a small market. Crohn's Disease -- a fairly small market, with no real evidence yet that the Isis drug would be the treatment of choice. Maybe a drug for kidney transplant, but no info is out on that. Cancer drugs? They look good so far, but they are years away. I'm begining to have nagging doubts about this company. Maybe its just that I had to much time to think over the weekend (ever wonder why stocks are usually down on Mondays?). In any case, I would like opinions on how you all think Isis is doing vis a vis their plans and expectations. sds